{{Rsnum
|rsid=10762058
|Gene=CTNNA3
|Chromosome=10
|position=68088508
|Orientation=plus
|GMAF=0.2204
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 4.6 | 32.3 | 63.1
| HCB | 6.7 | 35.6 | 57.8
| JPT | 2.2 | 48.9 | 48.9
| YRI | 6.3 | 39.7 | 54.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 6.7 | 35.6 | 57.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19187332
|Trait=Asthma (toluene diisocyanate-induced)
|Title=Alpha-T-catenin (CTNNA3) gene was identified as a risk variant for toluene diisocyanate-induced asthma by genome-wide association analysis
|RiskAllele=G
|Pval=0.000006
|OR=5.00
|ORtxt=[2.36-10.6]
}}

{{PharmGKB
|RSID=rs10762058
|Name_s=
|Gene_s=CTNNA3
|Feature=
|Evidence=PubMed ID:19187332; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Alpha-T-catenin (CTNNA3) gene was identified as a risk variant for toluene diisocyanate-induced asthma by genome-wide association analysis. (Initial Sample Size: 84 Korean cases, 263 Korean controls; Replication Sample Size: NR); (Region: 10q21.3; Reported Gene(s): CTNNA3; Risk Allele: rs10762058-G); (p-value= 0.000006).This variant is associated with Asthma (toluene diisocyanate-induced).
|Drugs=
|Drug Classes=
|Diseases=Asthma
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164739988
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10762058
|overall_frequency_n=100
|overall_frequency_d=122
|overall_frequency=0.819672
|n_genomes=51
|n_genomes_annotated=0
|n_haplomes=84
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}